Trademark Overview
On Thursday, February 8, 2024, a trademark application was filed for NALOX-ZONE with the United States Patent and Trademark Office. The USPTO has given the NALOX-ZONE trademark a serial number of 98397590. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 8, 2024. This trademark is owned by Board of Regents for the University of Wisconsin System. The NALOX-ZONE trademark is filed in the Education & Entertainment Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Education services, namely, focused on enhancing and promoting public awareness of the use of naloxone for opioid overdose reversal and expanding access to narcotic antagonists, including naloxone, in communities; Disseminating educational materials to spread awareness of the effectiveness of naloxone in treating opioid overdose; Offering educational opportunities and training on the appropriate use of naloxone; Addressing negative stigma faced by individuals with opioid use disorder through increasing the visibility and understanding of the life-saving pharmaceutical, naloxone
Health services, namely, harm reduction programs for individuals with opioid use disorder; offering medical assistance through kits containing pharmaceuticals, including narcotic antagonists like naloxone, to address opioid overdose; providing health information focused on reversing opioid drug overdose and promoting harm reduction strategies; educational services on the utilization of narcotic antagonists and associated supplies to effectively reverse opioid overdose
